Report Detail
Global Naloxegol Market 2022 by Company, Regions, Type and Application, Forecast to 2028
- RnM4478502 |
- 04 August, 2022 |
- Global |
- 102 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
The Naloxegol market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Naloxegol market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Naloxegol market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Pharmacy occupied for % of the Naloxegol global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Tablet segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Naloxegol include MOVANTIK, AstraZeneca, Aurobindo, MSN Life Sciences and Lepu, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Naloxegol market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Naloxegol companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Naloxegol market based on the following parameters – headquarters, products portfolio, Naloxegol revenue, and gross margin, recent developments.
Evaluation and forecast the Naloxegol market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Naloxegol market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
Tablet
Capsule
Market segment by Application (2017-2028; USD Million)
Pharmacy
Hospital
Clinic
Others
The key market players for global Naloxegol market are listed below:
MOVANTIK
AstraZeneca
Aurobindo
MSN Life Sciences
Lepu
Daiichi Sankyo Company
Knight Therapeutics
Kyowa Kirin International
Nektar Therapeutics
RedHill Biopharma Ltd.
Region Segment (2017-2028; USD Million)
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Naloxegol product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Naloxegol, with revenue, gross margin and global market share of Naloxegol from 2019 to 2022.
Chapter 3, the Naloxegol competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Naloxegol market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Naloxegol research findings and conclusion, appendix and data source.
1 Market Overview
- 1.1 Product Overview and Scope of Naloxegol
- 1.2 Classification of Naloxegol by Type
- 1.2.1 Overview: Global Naloxegol Market Size by Type: 2017 Versus 2021 Versus 2028
- 1.2.2 Global Naloxegol Revenue Market Share by Type in 2021
- 1.2.3 Tablet
- 1.2.4 Capsule
- 1.3 Global Naloxegol Market by Application
- 1.3.1 Overview: Global Naloxegol Market Size by Application: 2017 Versus 2021 Versus 2028
- 1.3.2 Pharmacy
- 1.3.3 Hospital
- 1.3.4 Clinic
- 1.3.5 Others
- 1.4 Global Naloxegol Market Size & Forecast
- 1.5 Global Naloxegol Market Size and Forecast by Region
- 1.5.1 Global Naloxegol Market Size by Region: 2017 VS 2021 VS 2028
- 1.5.2 Global Naloxegol Market Size by Region, (2017-2022)
- 1.5.3 North America Naloxegol Market Size and Prospect (2017-2028)
- 1.5.4 Europe Naloxegol Market Size and Prospect (2017-2028)
- 1.5.5 Asia-Pacific Naloxegol Market Size and Prospect (2017-2028)
- 1.5.6 South America Naloxegol Market Size and Prospect (2017-2028)
- 1.5.7 Middle East and Africa Naloxegol Market Size and Prospect (2017-2028)
- 1.6 Market Drivers, Restraints and Trends
- 1.6.1 Naloxegol Market Drivers
- 1.6.2 Naloxegol Market Restraints
- 1.6.3 Naloxegol Trends Analysis
2 Company Profiles
- 2.1 MOVANTIK
- 2.1.1 MOVANTIK Details
- 2.1.2 MOVANTIK Major Business
- 2.1.3 MOVANTIK Naloxegol Product and Solutions
- 2.1.4 MOVANTIK Naloxegol Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.1.5 MOVANTIK Recent Developments and Future Plans
- 2.2 AstraZeneca
- 2.2.1 AstraZeneca Details
- 2.2.2 AstraZeneca Major Business
- 2.2.3 AstraZeneca Naloxegol Product and Solutions
- 2.2.4 AstraZeneca Naloxegol Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.2.5 AstraZeneca Recent Developments and Future Plans
- 2.3 Aurobindo
- 2.3.1 Aurobindo Details
- 2.3.2 Aurobindo Major Business
- 2.3.3 Aurobindo Naloxegol Product and Solutions
- 2.3.4 Aurobindo Naloxegol Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.3.5 Aurobindo Recent Developments and Future Plans
- 2.4 MSN Life Sciences
- 2.4.1 MSN Life Sciences Details
- 2.4.2 MSN Life Sciences Major Business
- 2.4.3 MSN Life Sciences Naloxegol Product and Solutions
- 2.4.4 MSN Life Sciences Naloxegol Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.4.5 MSN Life Sciences Recent Developments and Future Plans
- 2.5 Lepu
- 2.5.1 Lepu Details
- 2.5.2 Lepu Major Business
- 2.5.3 Lepu Naloxegol Product and Solutions
- 2.5.4 Lepu Naloxegol Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.5.5 Lepu Recent Developments and Future Plans
- 2.6 Daiichi Sankyo Company
- 2.6.1 Daiichi Sankyo Company Details
- 2.6.2 Daiichi Sankyo Company Major Business
- 2.6.3 Daiichi Sankyo Company Naloxegol Product and Solutions
- 2.6.4 Daiichi Sankyo Company Naloxegol Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.6.5 Daiichi Sankyo Company Recent Developments and Future Plans
- 2.7 Knight Therapeutics
- 2.7.1 Knight Therapeutics Details
- 2.7.2 Knight Therapeutics Major Business
- 2.7.3 Knight Therapeutics Naloxegol Product and Solutions
- 2.7.4 Knight Therapeutics Naloxegol Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.7.5 Knight Therapeutics Recent Developments and Future Plans
- 2.8 Kyowa Kirin International
- 2.8.1 Kyowa Kirin International Details
- 2.8.2 Kyowa Kirin International Major Business
- 2.8.3 Kyowa Kirin International Naloxegol Product and Solutions
- 2.8.4 Kyowa Kirin International Naloxegol Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.8.5 Kyowa Kirin International Recent Developments and Future Plans
- 2.9 Nektar Therapeutics
- 2.9.1 Nektar Therapeutics Details
- 2.9.2 Nektar Therapeutics Major Business
- 2.9.3 Nektar Therapeutics Naloxegol Product and Solutions
- 2.9.4 Nektar Therapeutics Naloxegol Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.9.5 Nektar Therapeutics Recent Developments and Future Plans
- 2.10 RedHill Biopharma Ltd.
- 2.10.1 RedHill Biopharma Ltd. Details
- 2.10.2 RedHill Biopharma Ltd. Major Business
- 2.10.3 RedHill Biopharma Ltd. Naloxegol Product and Solutions
- 2.10.4 RedHill Biopharma Ltd. Naloxegol Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.10.5 RedHill Biopharma Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Naloxegol Revenue and Share by Players (2019, 2020, 2021, and 2022)
- 3.2 Market Concentration Rate
- 3.2.1 Top 3 Naloxegol Players Market Share in 2021
- 3.2.2 Top 10 Naloxegol Players Market Share in 2021
- 3.2.3 Market Competition Trend
- 3.3 Naloxegol Players Head Office, Products and Services Provided
- 3.4 Naloxegol Mergers & Acquisitions
- 3.5 Naloxegol New Entrants and Expansion Plans
4 Market Size Segment by Type
- 4.1 Global Naloxegol Revenue and Market Share by Type (2017-2022)
- 4.2 Global Naloxegol Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
- 5.1 Global Naloxegol Revenue Market Share by Application (2017-2022)
- 5.2 Global Naloxegol Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
- 6.1 North America Naloxegol Revenue by Type (2017-2028)
- 6.2 North America Naloxegol Revenue by Application (2017-2028)
- 6.3 North America Naloxegol Market Size by Country
- 6.3.1 North America Naloxegol Revenue by Country (2017-2028)
- 6.3.2 United States Naloxegol Market Size and Forecast (2017-2028)
- 6.3.3 Canada Naloxegol Market Size and Forecast (2017-2028)
- 6.3.4 Mexico Naloxegol Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
- 7.1 Europe Naloxegol Revenue by Type (2017-2028)
- 7.2 Europe Naloxegol Revenue by Application (2017-2028)
- 7.3 Europe Naloxegol Market Size by Country
- 7.3.1 Europe Naloxegol Revenue by Country (2017-2028)
- 7.3.2 Germany Naloxegol Market Size and Forecast (2017-2028)
- 7.3.3 France Naloxegol Market Size and Forecast (2017-2028)
- 7.3.4 United Kingdom Naloxegol Market Size and Forecast (2017-2028)
- 7.3.5 Russia Naloxegol Market Size and Forecast (2017-2028)
- 7.3.6 Italy Naloxegol Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
- 8.1 Asia-Pacific Naloxegol Revenue by Type (2017-2028)
- 8.2 Asia-Pacific Naloxegol Revenue by Application (2017-2028)
- 8.3 Asia-Pacific Naloxegol Market Size by Region
- 8.3.1 Asia-Pacific Naloxegol Revenue by Region (2017-2028)
- 8.3.2 China Naloxegol Market Size and Forecast (2017-2028)
- 8.3.3 Japan Naloxegol Market Size and Forecast (2017-2028)
- 8.3.4 South Korea Naloxegol Market Size and Forecast (2017-2028)
- 8.3.5 India Naloxegol Market Size and Forecast (2017-2028)
- 8.3.6 Southeast Asia Naloxegol Market Size and Forecast (2017-2028)
- 8.3.7 Australia Naloxegol Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
- 9.1 South America Naloxegol Revenue by Type (2017-2028)
- 9.2 South America Naloxegol Revenue by Application (2017-2028)
- 9.3 South America Naloxegol Market Size by Country
- 9.3.1 South America Naloxegol Revenue by Country (2017-2028)
- 9.3.2 Brazil Naloxegol Market Size and Forecast (2017-2028)
- 9.3.3 Argentina Naloxegol Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
- 10.1 Middle East & Africa Naloxegol Revenue by Type (2017-2028)
- 10.2 Middle East & Africa Naloxegol Revenue by Application (2017-2028)
- 10.3 Middle East & Africa Naloxegol Market Size by Country
- 10.3.1 Middle East & Africa Naloxegol Revenue by Country (2017-2028)
- 10.3.2 Turkey Naloxegol Market Size and Forecast (2017-2028)
- 10.3.3 Saudi Arabia Naloxegol Market Size and Forecast (2017-2028)
- 10.3.4 UAE Naloxegol Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
- 12.1 Methodology
- 12.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Naloxegol. Industry analysis & Market Report on Naloxegol is a syndicated market report, published as Global Naloxegol Market 2022 by Company, Regions, Type and Application, Forecast to 2028. It is complete Research Study and Industry Analysis of Naloxegol market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
